CVKD
Price
$13.33
Change
-$0.03 (-0.22%)
Updated
May 30 closing price
Capitalization
26.22M
67 days until earnings call
MNPR
Price
$31.73
Change
-$0.66 (-2.04%)
Updated
May 30 closing price
Capitalization
194.04M
Interact to see
Advertisement

CVKD vs MNPR

Header iconCVKD vs MNPR Comparison
Open Charts CVKD vs MNPRBanner chart's image
Cadrenal Therapeutics
Price$13.33
Change-$0.03 (-0.22%)
Volume$12.76K
Capitalization26.22M
Monopar Therapeutics
Price$31.73
Change-$0.66 (-2.04%)
Volume$17.08K
Capitalization194.04M
CVKD vs MNPR Comparison Chart
Loading...
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVKD vs. MNPR commentary
Jun 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVKD is a Buy and MNPR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 01, 2025
Stock price -- (CVKD: $13.33 vs. MNPR: $31.73)
Brand notoriety: CVKD and MNPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVKD: 61% vs. MNPR: 83%
Market capitalization -- CVKD: $26.22M vs. MNPR: $194.04M
CVKD [@Biotechnology] is valued at $26.22M. MNPR’s [@Biotechnology] market capitalization is $194.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $303.58B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVKD’s FA Score shows that 0 FA rating(s) are green whileMNPR’s FA Score has 0 green FA rating(s).

  • CVKD’s FA Score: 0 green, 5 red.
  • MNPR’s FA Score: 0 green, 5 red.
According to our system of comparison, MNPR is a better buy in the long-term than CVKD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVKD’s TA Score shows that 4 TA indicator(s) are bullish while MNPR’s TA Score has 4 bullish TA indicator(s).

  • CVKD’s TA Score: 4 bullish, 3 bearish.
  • MNPR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CVKD is a better buy in the short-term than MNPR.

Price Growth

CVKD (@Biotechnology) experienced а -9.63% price change this week, while MNPR (@Biotechnology) price change was -10.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.39%. For the same industry, the average monthly price growth was +0.48%, and the average quarterly price growth was -5.03%.

Reported Earning Dates

CVKD is expected to report earnings on Aug 07, 2025.

MNPR is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+1.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNPR($194M) has a higher market cap than CVKD($26.2M). MNPR YTD gains are higher at: 44.227 vs. CVKD (-8.006). MNPR has higher annual earnings (EBITDA): -7M vs. CVKD (-7.61M). CVKD has more cash in the bank: 10M vs. MNPR (6.02M). CVKD (0) and MNPR (0) have identical debt. CVKD (0) and MNPR (0) have equivalent revenues.
CVKDMNPRCVKD / MNPR
Capitalization26.2M194M14%
EBITDA-7.61M-7M109%
Gain YTD-8.00644.227-18%
P/E RatioN/AN/A-
Revenue00-
Total Cash10M6.02M166%
Total Debt00-
TECHNICAL ANALYSIS
Technical Analysis
CVKDMNPR
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 12 days ago
88%
Bullish Trend 18 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
78%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NET165.891.73
+1.05%
Cloudflare
BRZE36.800.36
+0.99%
Braze
MAG18.760.12
+0.64%
MAG Silver Corp
GLUE4.18-0.05
-1.18%
Monte Rosa Therapeutics
GBIO0.38-0.01
-2.58%
Generation Bio Co

CVKD and

Correlation & Price change

A.I.dvisor tells us that CVKD and MNPR have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVKD and MNPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVKD
1D Price
Change %
CVKD100%
-0.26%
MNPR - CVKD
29%
Poorly correlated
-2.04%
GDTC - CVKD
29%
Poorly correlated
N/A
WHWK - CVKD
25%
Poorly correlated
-6.11%
LQDA - CVKD
23%
Poorly correlated
-0.53%
GOSS - CVKD
22%
Poorly correlated
-1.77%
More

MNPR and

Correlation & Price change

A.I.dvisor tells us that MNPR and QNCX have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MNPR and QNCX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNPR
1D Price
Change %
MNPR100%
-2.04%
QNCX - MNPR
33%
Poorly correlated
N/A
CVKD - MNPR
29%
Poorly correlated
-0.26%
AKBLF - MNPR
29%
Poorly correlated
+4.01%
LOGC - MNPR
28%
Poorly correlated
+1.11%
BDRX - MNPR
26%
Poorly correlated
+1.89%
More